These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24703761)

  • 21. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
    Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
    Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam for people with mental retardation and refractory epilepsy.
    Kelly K; Stephen LJ; Brodie MJ
    Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam efficacy in children with epilepsy with electrical status epilepticus in sleep.
    Chen J; Cai F; Jiang L; Hu Y; Feng C
    Epilepsy Behav; 2015 Mar; 44():73-7. PubMed ID: 25632834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam reduces the frequency of interictal epileptiform discharges during NREM sleep in children with ADHD.
    Bakke KA; Larsson PG; Eriksson AS; Eeg-Olofsson O
    Eur J Paediatr Neurol; 2011 Nov; 15(6):532-8. PubMed ID: 21683631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
    Steinhoff BJ; Trinka E; Wieser HG;
    Seizure; 2005 Oct; 14(7):490-6. PubMed ID: 16169256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paroxysmal EEG abnormalities and epilepsy in pervasive developmental disorders: follow-up study until adolescence and beyond.
    Kawasaki Y; Shinomiya M; Takayanagi M; Niwa S
    Brain Dev; 2010 Oct; 32(9):769-75. PubMed ID: 20598460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
    Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
    Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
    Lee GH; Kim BM; Kang JK; Lee SA
    Seizure; 2013 Apr; 22(3):185-8. PubMed ID: 23280273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epileptic encephalopathy associated with forced normalization after administration of levetiracetam].
    Kikuchi T; Kato M; Takahashi N; Nakamura K; Hayasaka K
    No To Hattatsu; 2013 Sep; 45(5):375-8. PubMed ID: 24205693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EEG characteristics predict subsequent epilepsy in children with their first unprovoked seizure.
    Kanemura H; Sano F; Ohyama T; Mizorogi S; Sugita K; Aihara M
    Epilepsy Res; 2015 Sep; 115():58-62. PubMed ID: 26220377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEG characteristics predict subsequent epilepsy in children with febrile seizure.
    Kanemura H; Mizorogi S; Aoyagi K; Sugita K; Aihara M
    Brain Dev; 2012 Apr; 34(4):302-7. PubMed ID: 21959126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.
    Schiemann-Delgado J; Yang H; Loge Cde L; Stalvey TJ; Jones J; Legoff D; Mintz M
    J Child Neurol; 2012 Jan; 27(1):80-9. PubMed ID: 21876066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic effect of levetiracetam add-on treatment for frontal lobe epilepsy in 105 children].
    Zhang Y; Zhai Q; Tang Z; Zhuo M
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):364-7. PubMed ID: 24670450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Girl with Idiopathic Epilepsy Showing Forced Normalization after Levetiracetam Administration.
    Kawakami Y; Okazaki T; Takase M; Fujino O; Itoh Y
    J Nippon Med Sch; 2015; 82(5):250-3. PubMed ID: 26568392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P; Li Kan ; Maytal J
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy.
    Kossoff EH; Los JG; Boatman DF
    Epilepsy Behav; 2007 Dec; 11(4):514-7. PubMed ID: 17936689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.